APD vs ZYME · P/E 30, rev $12.04B vs rev $76.3M
Air Products and Chemicals Inc (APD) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Air Products and Chemicals Inc (APD) is a specialty chemicals company listed on NYSE.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported APD revenue for 2025-09-30 was $12.04B. Net income was -$354.4M. Revenue was down 0.5% from 2024-09-30 to 2025-09-30. APD currently screens at market cap $62.74B and trailing P/E 29.7.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
APD currently screens at market cap $62.74B and trailing P/E 29.7. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the APD and ZYME stock pages for the full models.
Not investment advice.